JPET Assistant Professor of Medicine (Clinician-Educator)

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hilal-Dandan, R.
Right arrow Articles by Brunton, L. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hilal-Dandan, R.
Right arrow Articles by Brunton, L. L.

Vol. 281, Issue 1, 267-273, 1997

The Quasi-irreversible Nature of Endothelin Binding and G Protein-Linked Signaling in Cardiac Myocytes1

Randa Hilal-Dandan, Sonia Villegas, Annette Gonzalez and Laurence L. Brunton

Departments of Pharmacology (R.H.-D., L.L.B.) and Medicine (L.L.B.) and the Biomedical Sciences Graduate Program (S.V., A.G.), University of California, San Diego, La Jolla, California

In experiments on neonatal and adult rat ventricular myocytes, endothelin (ET) binding and the effects of ET on transmembrane signaling are quasi-irreversible. The ETA receptor antagonist BQ123 competes for binding and biochemical effects if added simultaneously with ET; when added after ET, the antagonist prevents neither binding nor activation of the Gi and Gq pathways. At 4°C, at which internalization of the ligand should be minimized, the interaction of [125I]ET is still irreversible. After binding of radio-labeled ligand at either 4°C or 37°C, only 50% of ligand is removed by acid washing. Permeabilization of the cells with Triton X-100 fails to release irreversibly bound ligand. Binding experiments in cell membranes mimic this irreversible binding. At 37°C, the addition of mercaptoethanol or dithiothreitol inhibits concurrent ET binding but does not cause the dissociation of previously bound ligand or the reversal of previously activated signaling. We conclude that ET binds irreversibly to myocytes, that this irreversibility is reflected in the biochemical responses of the cells to ET and that the irreversibility is more complex than the formation of S---S bonds between surface receptors and ET or internalization of bound ET. We interpret these findings and others in the literature in light of a testable model of ETA receptor/G protein/effector interaction in which quasi-irreversible binding of ET to the ETA receptor occurs before the interaction of the ligand/receptor complex with G protein and in which irreversible binding contributes to the prolonged effects of ET and is a prelude to refractoriness and to the slow regeneration of free ETA receptor.


Copyright © by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
M. Tosun, Y. Erac, C. Selli, and N. Karakaya
Sarcoplasmic-endoplasmic reticulum Ca2+-ATPase inhibition prevents endothelin A receptor antagonism in rat aorta
Am J Physiol Heart Circ Physiol, April 1, 2007; 292(4): H1961 - H1966.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
P. J. Brighton, P. G. Szekeres, A. Wise, and G. B. Willars
Signaling and Ligand Binding by Recombinant Neuromedin U Receptors: Evidence for Dual Coupling to G{alpha}q/11 and G{alpha}i and an Irreversible Ligand-Receptor Interaction
Mol. Pharmacol., December 1, 2004; 66(6): 1544 - 1556.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
B. Boivin, D. Chevalier, L. R. Villeneuve, E. Rousseau, and B. G. Allen
Functional Endothelin Receptors Are Present on Nuclei in Cardiac Ventricular Myocytes
J. Biol. Chem., August 1, 2003; 278(31): 29153 - 29163.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
A. Talbodec, N. Berkane, V. Blandin, J. P. Breittmayer, E. Ferrari, C. Frelin, and P. Vigne
Aspirin and Sodium Salicylate Inhibit Endothelin ETA Receptors by an Allosteric Type of Mechanism
Mol. Pharmacol., April 1, 2000; 57(4): 797 - 804.
[Abstract] [Full Text]


Home page
CirculationHome page
C. P. Tiefenbacher, D. V. DeFily, and W. M. Chilian
Requisite Role of Cardiac Myocytes in Coronary {alpha}1-Adrenergic Constriction
Circulation, July 7, 1998; 98(1): 9 - 12.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
N. Bhowmick, P. Narayan, and D. Puett
The Endothelin Subtype A Receptor Undergoes Agonist- and Antagonist-Mediated Internalization in the Absence of Signaling
Endocrinology, July 1, 1998; 139(7): 3185 - 3192.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1997 by the American Society for Pharmacology and Experimental Therapeutics.